Screener
Relay Therapeutics, Inc. RLAY Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Relay Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Relay Therapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338056
FAQ
- What is Relay Therapeutics, Inc.'s total equity?
- Relay Therapeutics, Inc. (RLAY) reported total equity of $890.01M in Q2 2026.
- How has Relay Therapeutics, Inc.'s total equity changed year-over-year?
- Relay Therapeutics, Inc.'s total equity increased by 33.7% year-over-year, from $665.66M to $890.01M.
- What is the long-term trend for Relay Therapeutics, Inc.'s total equity?
- Over 5 years (2020 to 2025), Relay Therapeutics, Inc.'s total equity has grown at a -5.8% compound annual growth rate (CAGR), from $763.29M to $567.06M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Relay Therapeutics, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude